Recurrent Ovarian Cancer Patients subjected to Analysis of Clinical Cancer Gene Panels

Posted on

In recurrent ovarian cancer patients, the study shows success in providing patients with NGS-directed therapy. Molecular profiling can play an important role in making treatment decisions and will be a critical component in optimizing personalized medicine cancer care. Utilizing personalized medicine in high-volume clinical environments requires interdisciplinary expertise. The lack of an organized infrastructure in performing next generation sequencing (NGS), integrating these results into the electronic medical record (EMR), and guiding clinicians on how to interpret these tests for clinical decision making remains a barrier in the implementation of personalized medicine.

For more updates https://www.scitechnol.com/theranostics-international-journal.php

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s